Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Averion teams with Brazilian CRO
September 2007
SHARING OPTIONS:

BOSTON—Averion International Corp. and Brazil-based Biocancer in late August signed a non-exclusive agreement to jointly market and contract complementary services to biotechnology, pharmaceutical and medical device companies. Biocancer is a full-service site management and CRO with a focus on oncology. "This agreement expands our reach to South America, providing us with access to leading clinical sites and large patient populations," said Dr. Philip Lavin, Averion International's CEO. "In line with our strategy to achieve rapid market growth, we plan to continue building on our international oncology CRO offering through strategic partnerships and acquisitions. Biocancer has established relationships with highly qualified and experienced personnel, and we are pleased to partner with Biocancer as we grow our oncology CRO offering."
"As we help our clients plan and implement global development for new oncology agents, this alliance allows us to expand our sponsors' cost-effective access to high-quality medical facilities that can access common as well as rare forms of cancer," said Dr. Gene Resnick, Averion International CMO.
 

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.